Equity · Healthcare
INVA
NASDAQInnoviva, Inc.
The line runs $22.30 on 2 July through $21.49 on 19 August, on a scale from $20 to $23. Days the market did not trade hold the previous close, flat.
The chart above plots the price of INVA over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 34 sessions over that window: $22.30 on 2 July 2026 through $21.49 on 19 August 2026.
Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Aug 19, 2026
INVA insider trades
INVA has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 20 November 2025.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
INVA reported financials
INVA reported revenue of $411.3M for the fiscal year ended 31 Dec 2025. Net income over the same period was $271.2M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
INVA earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
INVA institutional holders
8 of the 45 institutional funds we track reported a INVA position for the quarter ended 30 Jun 2026 — a combined $232.8M; the latest of those filings landed 02 Sep 2026.
Source: SEC EDGAR 13F filings
INVA fails-to-deliver
On 04 Sep 2026, 49 shares of INVA failed to deliver (about $1K) — the latest of 2 consecutive trading days with recorded fails.
Source: SEC fails-to-deliver (CNS) data
Congressional trades in INVA
The most recent congressional trade disclosed in INVA is a sale by George Whitesides (house, CA), dated 25 Mar 2025.
Source: U.S. House of Representatives financial disclosures